uqudenlid.blogspot.com
Lead Therapeutics is developing drugs for cancer and infectious diseases. According to the SEC the San Bruno, Calif., company has raised $3 million so far in the Other investors include ProQuest Investmentsof Princeton, and Mustang Ventures, a venture capital firm based in Shanghai, China. Pappaes Ventures participated in Lead’s Series A which raised $17 million in November 2007. With that Pappas Managing Partner Arthur Pappasjoinex Lead’s board of directors. Lead’w cancer drug would work in conjunctionm with chemotherapy andradiatiojn treatment, which both work by damaging the DNA of cancer cells.
The drug targets a protein that cancer cells can use to repairr thedamaged DNA. The company expects to select a lead compoundin mid-200i9 and begin clinical trials by
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment